Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mouse
epidermal growth factor
(
EGF
) was covalently conjugated with the water-soluble polymer, poly(acrylic acid) (
EGF
-
PAA
), or with the water-insoluble polymer, surface-hydrolyzed poly(methyl methacrylate) (
EGF
-PMMA). Immobilized
EGF
(
EGF
-PMMA) stimulated DNA synthesis in Chinese hamster ovary cells overexpressing
EGF
receptors in amounts that were 5 to 10% of those of free
EGF
required for comparable effects. In addition, the maximal mitogenic effect of
EGF
-PMMA was greater than that of unconjugated
EGF
or
EGF
-
PAA
.
EGF
,
EGF
-
PAA
, and
EGF
-PMMA induced the autophosphorylation of
EGF
receptors and the stimulation of mitogen-activated protein kinase. However, whereas the onset of these effects was delayed with
EGF
-PMMA, they persisted for much longer than those of
EGF
and
EGF
-
PAA
. Unlike
EGF
and
EGF
-
PAA
,
EGF
-PMMA was not associated with cells after their removal from culture and did not induce receptor internalization. Culturing cells with PMMA-immobilized
EGF
thus represents a model system for studying "juxtacrine" stimulation of cells by membrane-bound growth factors.
...
PMID:Enhancement of the mitogenic effect by artificial juxtacrine stimulation using immobilized EGF. 913 20